Goldman Sachs’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $20.8M | Buy |
|
|||||
|
2022
Q4 | $2.32M | Sell |
|
|||||
|
2022
Q3 | $1.01M | Sell |
|
|||||
|
2022
Q2 | $1.37M | Buy |
|
|||||
|
2022
Q1 | $1.78M | Sell |
|
|||||
|
2021
Q4 | $1.51M | Buy |
|
|||||
|
2021
Q3 | $1.34M | Sell |
|
|||||
|
2021
Q2 | $2.8M | Sell |
|
|||||
|
2021
Q1 | $3.57M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Sell |
|
|||||
|
2020
Q3 | $1.72M | Buy |
|
|||||
|
2020
Q2 | $1.5M | Buy |
|
|||||
|
2020
Q1 | $959K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $36K | Sell |
|
|||||
|
2018
Q4 | $35K | Sell |
|
|||||
|
2018
Q3 | $88K | Buy |
|